Trends like low-calorie diets, diet sodas and low-fat snacks dominated the weight-management space for decades, but the landscape has shifted to a holistic focus in recent years – covering metabolic health, mental well-being, immunity, longevity and tools to aid in weight loss.
One aspect of this is that many consumers are now integrating anti-obesity medications (AOMs) into a larger health-and-wellness plan. These include GLP-1s like Ozempic®, Wegovy®, Trulicity® and more. IFF is closely monitoring these market trends and consumer preferences.
We offer support to our partners in the food industry, developing great-tasting, nutritious solutions tailored for consumers on AOMs and those simply pursuing better health. Together, let’s expand the palette of offerings to complement consumers on their quest.
Download this resource and explore how GLP-1 medications are changing food and beverage behaviors and where the biggest opportunities lie. Inside, you’ll find consumer insights, market projections, strategic guidance and actionable guidance.
The Multibillion-Dollar GLP-1 Consumer-Market Opportunity
Missed our live webinar? Watch the full recording to explore five key areas transforming food and beverage innovation.
Weight-management programs and a reduced-calorie, high-protein diet can help consumers achieve their muscle-building and weight-management goals.
High-quality protein sources like IFF SUPRO® soy protein can even increase satiety, making it easier for consumers to stick to their dietary plans.
With high-protein, reduced-sugar products, it’s critical to achieve a positive mouthfeel and overall taste, masking off-notes for consumers.
IFF offers solutions like flavor tonalities, texturants, emulsifiers, modulation technologies and system blends to deliver higher fiber content and assist with taste and texture.
Consumers, especially those on AOMs, need a balance of probiotics and soluble fiber for ideal digestive health. Our solutions include HOWARU® premium probiotics and Litesse® soluble fiber, as well as IFF enzymes to reduce lactose content.
At IFF, we bring unmatched expertise and forward-thinking, weight-management solutions, especially for those on GLP-1s and other anti-obesity medications.
Backed by deep industry insights and cutting-edge IFF PRODUCT DESIGN™, we help our Food & Beverage customers stay ahead and stand apart.
Partner with us to learn more about IFF’s weight-management solutions for better taste, texture, nutrition and hydration.
Once you submit the form, one of our experts will reach out and you’ll receive our Weight-Management Infographic, which features exclusive insights on GLP-1 consumers.